Does the risk of arterial hypertension increase in the course of triptorelin treatment?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Pediatric Endocrinology and Metabolism"
DOI: 10.1515/jpem-2018-0210
Abstract: Abstract Background: Gonadotropin-releasing hormone agonists (GnRH-a) are common treatment options for central precocious puberty (CPP) in childhood. GnRH-a treatment is useful and has a good safety profile, with minimal adverse effects and no severe long-term… read more here.
Keywords: arterial hypertension; treatment; triptorelin treatment; risk arterial ... See more keywords